<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; systems</title>
	<atom:link href="http://www.tapanray.in/tag/systems/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Create Greater Patient–Value To Excel With Repurposed Covid Brands</title>
		<link>http://www.tapanray.in/create-greater-patient-value-to-excel-with-repurposed-covid-brands/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=create-greater-patient-value-to-excel-with-repurposed-covid-brands</link>
		<comments>http://www.tapanray.in/create-greater-patient-value-to-excel-with-repurposed-covid-brands/#comments</comments>
		<pubDate>Mon, 23 Nov 2020 00:00:11 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[antivirals]]></category>
		<category><![CDATA[Clinical]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[create]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inhaler]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[molecule]]></category>
		<category><![CDATA[NDDS]]></category>
		<category><![CDATA[novel]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Relevance]]></category>
		<category><![CDATA[repurposed]]></category>
		<category><![CDATA[segments]]></category>
		<category><![CDATA[small]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10335</guid>
		<description><![CDATA[Regular introduction of new molecules, line extensions or a Novel Drug delivery System (NDDS) has remained the life blood for pharma to rejuvenate a company’s product portfolio for driving organizational growth. But, Covid’s unprecedented and devastating assault on human lives &#8230; <a href="http://www.tapanray.in/create-greater-patient-value-to-excel-with-repurposed-covid-brands/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/create-greater-patient-value-to-excel-with-repurposed-covid-brands/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2015: Pharma Industry Achieved Some, Could Achieve Some More</title>
		<link>http://www.tapanray.in/2015-pharma-industry-achieved-some-could-achieve-some-more/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=2015-pharma-industry-achieved-some-could-achieve-some-more</link>
		<comments>http://www.tapanray.in/2015-pharma-industry-achieved-some-could-achieve-some-more/#comments</comments>
		<pubDate>Mon, 04 Jan 2016 00:00:18 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2015]]></category>
		<category><![CDATA[2016]]></category>
		<category><![CDATA[achieved]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[discovery]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[engagement]]></category>
		<category><![CDATA[Google]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[inhaler]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[Novo Nordisk]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research. delivery]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[smart]]></category>
		<category><![CDATA[Social media]]></category>
		<category><![CDATA[Some]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7378</guid>
		<description><![CDATA[Wish You And All Your Near And Dear Ones Peace, Happiness, Good Health And Prosperity in The Brand New Year 2016  The year 2015 witnessed several noteworthy developments in the pharma industry, just as many other years before. That said, &#8230; <a href="http://www.tapanray.in/2015-pharma-industry-achieved-some-could-achieve-some-more/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/2015-pharma-industry-achieved-some-could-achieve-some-more/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Public Healthcare Space: Evaluating Three Fresh Edicts</title>
		<link>http://www.tapanray.in/public-healthcare-space-evaluating-three-fresh-edicts/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=public-healthcare-space-evaluating-three-fresh-edicts</link>
		<comments>http://www.tapanray.in/public-healthcare-space-evaluating-three-fresh-edicts/#comments</comments>
		<pubDate>Mon, 02 Dec 2013 00:00:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2010]]></category>
		<category><![CDATA[CE]]></category>
		<category><![CDATA[Clinical]]></category>
		<category><![CDATA[CMSS]]></category>
		<category><![CDATA[Council]]></category>
		<category><![CDATA[edicts]]></category>
		<category><![CDATA[Essential]]></category>
		<category><![CDATA[Establishment Act]]></category>
		<category><![CDATA[Establishments]]></category>
		<category><![CDATA[evaluating]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Free]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[laudative]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[model]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[NCCE]]></category>
		<category><![CDATA[off]]></category>
		<category><![CDATA[oop]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[ready]]></category>
		<category><![CDATA[Standard]]></category>
		<category><![CDATA[steps]]></category>
		<category><![CDATA[STG]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[take]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[welcoming]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=4307</guid>
		<description><![CDATA[Medicines constitute a significant cost component of modern healthcare systems across the world. However, in India the situation is even worse, where as per recent studies, drugs contribute as high as around 70 percent of the total treatment cost. This &#8230; <a href="http://www.tapanray.in/public-healthcare-space-evaluating-three-fresh-edicts/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/public-healthcare-space-evaluating-three-fresh-edicts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Supreme Court Suspends New Drug Trials in India&#8230;Time to Shape Up?</title>
		<link>http://www.tapanray.in/supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up</link>
		<comments>http://www.tapanray.in/supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up/#comments</comments>
		<pubDate>Mon, 14 Oct 2013 00:00:21 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[advisory]]></category>
		<category><![CDATA[AE]]></category>
		<category><![CDATA[biologics]]></category>
		<category><![CDATA[CAC]]></category>
		<category><![CDATA[CDSCO]]></category>
		<category><![CDATA[ceravix]]></category>
		<category><![CDATA[Chaudhury]]></category>
		<category><![CDATA[Clinical]]></category>
		<category><![CDATA[Committee]]></category>
		<category><![CDATA[compensation]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[Court]]></category>
		<category><![CDATA[CT]]></category>
		<category><![CDATA[CTs]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[deaths]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[DTAB]]></category>
		<category><![CDATA[expert]]></category>
		<category><![CDATA[exploitation]]></category>
		<category><![CDATA[gardasil]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[mechanisms]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Ministry]]></category>
		<category><![CDATA[MNCs]]></category>
		<category><![CDATA[NCE]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NME]]></category>
		<category><![CDATA[Parliamentary]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PIL]]></category>
		<category><![CDATA[PSC]]></category>
		<category><![CDATA[Ranjit]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulations]]></category>
		<category><![CDATA[Roy]]></category>
		<category><![CDATA[SAE]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[SC]]></category>
		<category><![CDATA[Shape]]></category>
		<category><![CDATA[standing Committee]]></category>
		<category><![CDATA[stops]]></category>
		<category><![CDATA[Supreme]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[TRC]]></category>
		<category><![CDATA[Trials]]></category>
		<category><![CDATA[Up]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=3839</guid>
		<description><![CDATA[On September 30, 2013, with a damning stricture to the Drug Regulator, the Supreme Court, in response to a Public Interest Litigation (PIL) filed by the NGO Swasthya Adhikar Manch, stayed approvals for 162 applications for local Clinical Trials (CTs) of new &#8230; <a href="http://www.tapanray.in/supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Collaborative commercialization of inexpensive smaller incremental innovation in Chemistry will play an important role in bringing affordable new drugs or new drug delivery systems</title>
		<link>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems</link>
		<comments>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/#comments</comments>
		<pubDate>Mon, 28 Dec 2009 00:30:28 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[bringing]]></category>
		<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Collaborative]]></category>
		<category><![CDATA[commercialization]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[important]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[incremental]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inexpensive]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[NDDS]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[Oxford]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[play]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[role]]></category>
		<category><![CDATA[smaller]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[UK]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=685</guid>
		<description><![CDATA[It started in the 17th century: Alchemy, a medieval chemical science and speculative philosophy aiming to achieve the transmutation of the base metals into gold, searching for a universal cure for disease and indefinitely prolonging life, not considered a science &#8230; <a href="http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Increasing socio-economic inequality within the healthcare delivery systems of India</title>
		<link>http://www.tapanray.in/increasing-socio-economic-inequality-within-the-healthcare-delivery-systems-of-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=increasing-socio-economic-inequality-within-the-healthcare-delivery-systems-of-india</link>
		<comments>http://www.tapanray.in/increasing-socio-economic-inequality-within-the-healthcare-delivery-systems-of-india/#comments</comments>
		<pubDate>Mon, 31 Aug 2009 01:00:44 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Increasing]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inequality]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[within]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=792</guid>
		<description><![CDATA[Increasing inequality between the wide diversity of population of ‘haves’ and ‘have-nots’ in the socio-economic and cultural set up of India, clearly gets reflected in the healthcare delivery system of the country. Many research studies on this subject have established &#8230; <a href="http://www.tapanray.in/increasing-socio-economic-inequality-within-the-healthcare-delivery-systems-of-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/increasing-socio-economic-inequality-within-the-healthcare-delivery-systems-of-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
